Tus kws kho mob
P11GA_17078627-Site-of-Service-GI_Exempt-Hospitals-021920.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2471 - 2480 ntawm 3685
Tus kws kho mob
QP31R1-20 Update: Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP54-20 MHCP Pharmacy Benefit Update — Pharmacy Benefit Exclusion for Nexplanon® and Trodelvy™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP57-20 Commercial Pharmacy Benefit Update: Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP53-20 Commercial Pharmacy Benefit Exclusion for Nexplanon®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP56-20 U.S. Department of Health and Human Services Announced Additional Opportunity for Funding
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 24, 2020
Tus kws kho mob
QP49-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema (HAE)
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 10, 2020
Tus kws kho mob
P47-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective August 31, 2020
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 01, 2020